BETAMETHASONE DIPROPIONATE | N018741 | ORGANON LLC A SUB OF ORGANON AND CO
| Trial | Phase | Status | Sponsor | Enrollment | Dates |
|---|---|---|---|---|---|
| Phase 2/3 | By Invitation | Wake Forest University Health Sciences | 40 | 2024-07-15 → 2027-12 | |
| Phase 4 | Not Yet Recruiting | Cairo University | 40 | 2026-08-01 → 2027-01 | |
| Phase 2/3 | Not Yet Recruiting | Peking Union Medical College Hospital | 126 | 2026-07 → 2028-07 | |
| N/A | Not Yet Recruiting | Sohag University | 60 | 2026-06-28 → 2027-12-28 | |
| N/A | Recruiting | Mansoura University | 72 | 2026-01-06 → 2027-02 | |
| N/A | Recruiting | Istanbul University - Cerrahpasa | 42 | 2026-06-30 → 2027-05 | |
| Phase 4 | Recruiting | Baylor College of Medicine | 40 | 2026-05-08 → 2027-12 | |
| Phase 4 | Recruiting | Wake Forest University Health Sciences | 250 | 2018-04-30 → 2027-03 | |
| Phase 4 | Completed | Odense University Hospital | 134 | 2017-01-09 → 2017-08-29 | |
| Phase 2 | Completed | LEO Pharma | 24 | 2009-04 → 2009-07 |
Source: ClinicalTrials.gov. Trials matched by ingredient name; data refreshed each weekday and may lag the registry.
Lowest Price
$2.15
Highest Price
$241.03
FSS NDCs
3
Big4 NDCs
3
| Description | Price | Type | Vendor | Contract End |
|---|---|---|---|---|
| 66993-0897-15BETAMETHASONE DIPROPIONATE 0.05% AUGMENTED OI | $2.15 | Big4 | Prasco, LLC | 06/30/2026 |
| 66993-0897-15BETAMETHASONE DIPROPIONATE 0.05% AUGMENTED OI | $46.35 | FSS | Prasco, LLC | 06/30/2026 |
| 78206-0124-01DIPROLENE 0.05% OINTMENT | $80.17 | Big4 | Organon LLC | 01/14/2027 |
| 78206-0124-01DIPROLENE 0.05% OINTMENT | $107.65 | FSS | Organon LLC | 01/14/2027 |
| 78206-0124-02DIPROLENE 0.05% OINTMENT | $179.42 | Big4 | Organon LLC | 01/14/2027 |
| 78206-0124-02DIPROLENE 0.05% OINTMENT | $241.03 | FSS | Organon LLC | 01/14/2027 |
Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.
Total Spending
$13K
Total Claims
64
Beneficiaries
30
Avg Cost/Unit
$4.08
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.
9 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| May 2, 2019 | SUPPL -40 | View Letter (PDF) |
| Apr 1, 2018 | SUPPL -38 | View Letter (PDF) |
| Aug 14, 2014 | SUPPL -36 | View Letter (PDF) |
| Sep 18, 2006 | SUPPL -28 | View Letter (PDF) |
| Feb 22, 2006 | SUPPL -16 | View Letter (PDF) |
| Oct 14, 2005 | SUPPL -16 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.